Siena Capital’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.55M Buy
33,604
+518
+2% +$42.9K 1.66% 22
2022
Q2
$2.8M Buy
33,086
+507
+2% +$44.5K 1.69% 20
2022
Q1
$2.86M Buy
32,579
+7,431
+30% +$643K 1.61% 23
2021
Q4
$2.2M Buy
+25,148
New +$2.09M 1.26% 24

Other funds holding NVS

Siena Capital's NVS Position: Q3 2022 in Review

Siena Capital increased its Novartis (NVS) stake by 1.6% in Q3 2022, buying an estimated $42.9K and bringing the position to 33,604 shares worth $2.55M. The position accounts for 1.66% of the portfolio, ranked #22.

Siena Capital first reported a position in NVS in Q4 2021 and has held it in 4 quarters since. The position peaked at $2.86M in Q1 2022. 1,088 funds tracked by Wall St. Rank hold NVS as of Q3 2022.

  • Siena Capital held 33,604 shares of Novartis worth $2.55M as of Q3 2022.
  • Siena Capital bought 518 Novartis shares in Q3 2022, an estimated $42.9K.
  • Novartis made up 1.66% of Siena Capital's portfolio in Q3 2022, its #22 holding.
  • Siena Capital first reported a position in Novartis in Q4 2021 and has held it in 4 quarters since.
  • Siena Capital's Novartis position peaked at $2.86M in Q1 2022.
  • 1,088 funds tracked by Wall St. Rank held Novartis as of Q3 2022.

Based on Siena Capital's 13F filing for Q3 2022, filed 2 Nov 2022.